Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
Deutsche Medizinische Wochenschrift (1946)
|
August 20, 1971
[Decrease of transfusion hepatitis following introduction of transaminases and Australia (SH)-antigen determination in blood donors]
H J Arndt, R Frese, K Nachtwey, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin
|
January 1, 1971
[Decrease in the occurrence of transfusion hepatitis in Göttingen hospitals following the introduction of routine transaminase and Australia antigen determination in blood donors]
H J Arndt, R Frese, K Nachtwey, et al.
Der Anaesthesist
|
April 1, 1976
[Haemodynamics, oxygen demand and oxygen uptake of the heart during isovolaemic haemodilution (author's transl)]
D Kettler, K Hellberg, G Klaess, et al.
Der Anaesthesist
|
April 1, 1976
[Haemodynamics and tolerance to hypoxia of the myocardium under 6%-oxygen ventilation following acute isovolaemic haemodilution in experimental animals (author's transl)]
W Loos, K Kettler, K Hellberg, et al.
Behaviour Research and Therapy
|
May 1, 1995
Effects of varying scoring rules of the Clinician-Administered PTSD Scale (CAPS) for the diagnosis of post-traumatic stress disorder in motor vehicle accident victims
E B Blanchard, E J Hickling, A E Taylor, et al.
Geburtshilfe Und Frauenheilkunde
|
July 1, 1988
[Puerperal ovarian vein thrombophlebitis--a rare puerperal complication]
W Loos, R von Hugo, W Rath, et al.
British Journal of Cancer
|
September 29, 2004
Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1-5 of a 3-weekly cycle in patients with advanced solid tumours
M J A de Jonge, S Kaye, J Verweij, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1996
Phase II and pharmacologic study of topotecan administered as a 21-day continuous infusion to patients with colorectal cancer
G J Creemers, C J Gerrits, J H Schellens, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
Deutsche Medizinische Wochenschrift (1946)
|
August 20, 1971
[Decrease of transfusion hepatitis following introduction of transaminases and Australia (SH)-antigen determination in blood donors]
H J Arndt, R Frese, K Nachtwey, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin
|
January 1, 1971
[Decrease in the occurrence of transfusion hepatitis in Göttingen hospitals following the introduction of routine transaminase and Australia antigen determination in blood donors]
H J Arndt, R Frese, K Nachtwey, et al.
Der Anaesthesist
|
April 1, 1976
[Haemodynamics, oxygen demand and oxygen uptake of the heart during isovolaemic haemodilution (author's transl)]
D Kettler, K Hellberg, G Klaess, et al.
Der Anaesthesist
|
April 1, 1976
[Haemodynamics and tolerance to hypoxia of the myocardium under 6%-oxygen ventilation following acute isovolaemic haemodilution in experimental animals (author's transl)]
W Loos, K Kettler, K Hellberg, et al.
Behaviour Research and Therapy
|
May 1, 1995
Effects of varying scoring rules of the Clinician-Administered PTSD Scale (CAPS) for the diagnosis of post-traumatic stress disorder in motor vehicle accident victims
E B Blanchard, E J Hickling, A E Taylor, et al.
Geburtshilfe Und Frauenheilkunde
|
July 1, 1988
[Puerperal ovarian vein thrombophlebitis--a rare puerperal complication]
W Loos, R von Hugo, W Rath, et al.
British Journal of Cancer
|
September 29, 2004
Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1-5 of a 3-weekly cycle in patients with advanced solid tumours
M J A de Jonge, S Kaye, J Verweij, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1996
Phase II and pharmacologic study of topotecan administered as a 21-day continuous infusion to patients with colorectal cancer
G J Creemers, C J Gerrits, J H Schellens, et al.
Page
of 4